Dr. Tom Skaria
Dr. Tom Skaria
Assistant Professor
Office Address:
Room 304-2 , Bioscience and Engineering, National Institute of Technology (NIT) Calicut, NIT campus P O, Calicut-673601
Dr. of Science , University of Zurich, Switzerland.
PhD course work in Immunology from ETH Zurich (Swiss Federal Institute of Technology), Switzerland
Educational Qualifications
-
Dr. of Science , University of Zurich, Switzerland.
-
PhD course work in Immunology from ETH Zurich (Swiss Federal Institute of Technology), Switzerland
Journals
- Ahsan Anjoom Sunil, Tom Skaria. Novel regulators of airway epithelial barrier function during inflammation: potential targets for drug repurposing. Expert Opinion on Therapeutic Targets. 2022.
- Tom Skaria, Johannes Vogel. The Neuropeptide a-Calcitonin Gene-Related Peptide as the Mediator of Beneficial Effects of Exercise in the Cardiovascular System. Frontiers in Physiology. 2022.
- Tom Skaria, Mostafa A Aboouf Ali, Johannes Vogel. Improved method for surgical induction of chronic hypertension in mice. Biology Open. 2022
- Tom Skaria, Esther Bachli, Gabriele Schoedon. Transcriptional Regulation of Drug Metabolizing CYP Enzymes by Proinflammatory Wnt5A Signaling in Human Coronary Artery Endothelial Cells. Frontiers in Pharmacology, 2021; 12:619588.
- Tom Skaria, Thomas Wälchli, Johannes Vogel. CGRP Receptor Antagonism in COVID-19: Potential Cardiopulmonary Adverse Effects. Trends in Molecular Medicine. 27, 7 -10, 2020.
- Tom Skaria, Katharyn Mitchell, Olga Vogel, Thomas Walchli, Max Gassmann, Johannes Vogel. Blood pressure normalization-independent cardioprotective effects of endogenous, physical activity-induced alpha calcitonin gene-related peptide (CGRP) in chronic hypertension. Circulation Research. 125, 1124- 1140, 2019.
- Tom Skaria, Esther Bachli, Gabriele Schoedon. Gene Ontology Analysis for Drug Targets of the Whole Genome Transcriptome of Human Vascular Endothelial Cells in Response to Proinflammatory IL-1. Front. Pharmacol. 2019; 10:414.
- Tom Skaria, Esther Bachli, Gabriele Schoedon. RSPO3 impairs barrier function of human vascular endothelial monolayers and synergizes with pro-inflammatory IL-1. Molecular Medicine. 2018:24:45.
- Tom Skaria, Gabriele Schoedon. Inflammatory Wnt5A signalling pathways affecting barrier function of human vascular endothelial cells. J Inflamm (Lond). 2017;14:15.
- Tom Skaria, Esther Bachli, Gabriele Schoedon. WIF1 prevents Wnt5A mediated LIMK/CFL phosphorylation and adherens junction disruption in human vascular endothelial cells. J Inflamm (Lond). 2017;14:10.
- Tom Skaria, Julia Burgener, Esther Bachli, Gabriele Schoedon. IL-4 causes hyperpermeability of vascular endothelial cells through Wnt5A signaling. 2016. PLoS ONE. 2016; 11:e0156002.
- Tom Skaria, Esther Bachli, Gabriele Schoedon. Wnt5A/Ryk Signalling Critically Affects Barrier Function in Human Vascular Endothelial Cells. Cell Adh Migr. 2017 J;11(1):24-38.
- René Günther Feichtinger, Daniel Neureiter, Tom Skaria, Silja Wessler, Timothy L Cover, Johannes Adalbert Mayr, Franz A Zimmermann, Gernot Posselt, Wolfgang Sperl, Barbara Kofler. Oxidative phosphorylation system in gastric carcinomas and gastritis. Oxidative Medicine and Cellular Longevity. 2017;1320241: 1- 15.
Professional Experience
-
Post-Doctoral Scientist (full time) at Zurich Center for Integrative Human Physiology & Institute of Veterinary Physiology, University of Zürich, Switzerland, from 01/11/2015 till 31/03/2020
-
Scientific Collaborator at Inflammation Research Unit, Division of Internal Medicine, University Hospital of University of Zürich, Switzerland 16/05/2015 to date